This national seminar explores what it’s really like to live with myeloma in regional, rural, and remote Australia, and how care can be accessed closer to home despite geographical challenges.
Clinical and laboratory haematologist Louise Inlay Gillespie provides a clear overview of what myeloma is, how it develops, common symptoms, and how it’s treated over time. She explains key concepts such as paraproteins, light chains, MGUS and smouldering myeloma, and walks through current treatment pathways, including first-line therapy, stem cell transplant, later-line treatments, supportive care, and the role of clinical trials. Louise also discusses how treatment goals and quality of life are balanced across different stages of disease, particularly for people living outside major cities.
Associate Professor Kate Burberry introduces tele trials, a national strategy designed to improve access to clinical trials regardless of location. Using real Australian data, she explains how tele trials work, what parts of a trial can be done locally, and how this model reduces travel, improves recruitment, and allows regional patients to participate in cutting-edge research without relocating to metropolitan centres.
Nurse Practitioner Karen Young shares practical insights into delivering myeloma care in regional Western Australia. She outlines common challenges such as delayed diagnosis, access to specialist services, travel burdens, and medication logistics, while highlighting solutions including telehealth, local chemotherapy units, tele-chemotherapy and tele-radiotherapy services, care coordinators, nurse practitioners, allied health, and patient travel assistance schemes.
The seminar concludes with a lived experience discussion featuring Alan and Ros from rural New South Wales, who reflect on long-term myeloma treatment, the realities of travel and side effects, the importance of self-advocacy, seeking second opinions, and staying informed as new treatments emerge.
This webinar offers practical guidance, reassurance, and advocacy-focused information for people living with myeloma, their carers, and health professionals supporting patients outside metropolitan areas.
Keep watching
Watch our other webinars
-
Blood, bones and the tip of the iceberg: Myeloma markers and monitoring
Professor Simon Harrison provides a clear overview of how myeloma is diagnosed, monitored and assessed over time.
-
Common myeloma side effects and strategies to improve quality of life
Haematologist Joy Ho discusses common side effects of myeloma and its treatments, with practical strategies to support quality of life. The presentation covers peripheral neuropathy,…
-
Myeloma Carer’s toolkit
Myeloma Specialist Nurse Lucy Murphy shares practical guidance for people caring for someone with myeloma. She discusses the carer’s role, informed decision-making, practical support, communication,…
-
Bi-specific and tri-specific T cell engagers for the treatment of myeloma
Professor Hang Quach explains how bispecific and trispecific T-cell engagers are changing multiple myeloma treatment. He discusses how these therapies work, current and emerging treatment…
-
Travel and myeloma- National myeloma month 2022
Senior Myeloma Specialist Nurse Jo discusses travel and myeloma, including planning with your treating team, medications, medical letters, vaccinations, travel insurance, infection precautions and practical…
-
National myeloma update 2025
Prof. Miles Prince’s 2025 myeloma update: from chemo to cutting-edge immunotherapies like CAR-T & bispecifics. Learn about new treatments, access, and the future of care
-
Exploring impacts of new technology
Associate Professor Edwin Hawkins explores how myeloma cells interact with the bone marrow microenvironment and evade immune responses. Using advanced imaging and spatial transcriptomics, this…
-
Supportive care and mental health and wellbeing
Psychologist Natalie Tucky discusses mental health, supportive care, self-advocacy, and wellbeing for people living with myeloma and precursor conditions.
-
Your immune system- Supporting immune function
Learn how multiple myeloma affects the immune system, why infection risk is higher, and how treatments like immunoglobulin replacement, vaccines, and antibiotics are used to…
-
Autologous stem cell transplant
Clinical Nurse Consultant Jenny Paul explains the autologous stem cell transplant process for myeloma, covering mobilisation, chemotherapy, reinfusion, side-effect management, and long-term recovery in a…
Connect with us
Stay informed with the latest myeloma research, treatment updates, and support resources. We offer tailored newsletters for both patients and healthcare professionals with relevant information and community updates.
